https://www.selleckchem.com/pr....oducts/qnz-evp4593.h
Complications were recorded. The mean VAS score decreased from 6.3 at baseline in both groups to 2.0 in the F-ESWT group versus 4.7 in the control group at 2 months; the 2-month score differed significantly between groups (p 0.001). All secondary outcomes at all follow-up intervals were significantly better in the F-ESWT group, except for the LEFS score at 1 month after treatment (p = 0.25). No complications were observed. F-ESWT in association with a specific exercise program is safe and effective for GTPS, with a success rate
Like
Comment
Share
